{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:35:38Z","timestamp":1781022938154,"version":"3.54.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vaccine.2018.03.053","type":"journal-article","created":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T04:08:35Z","timestamp":1522555715000},"page":"2523-2528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["The public health value of vaccination for seniors in Europe"],"prefix":"10.1016","volume":"36","author":[{"given":"Susanna","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetan","family":"Gavazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel Gil","family":"de Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Hardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kassianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-C\u00e9cile","family":"Levant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Soubeyrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"L\u00f3pez Trigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.03.053_b0005","unstructured":"OECD. Health at a Glance 2015. OECD Publishing."},{"key":"10.1016\/j.vaccine.2018.03.053_b0010","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1473-3099(02)00437-1","article-title":"Ageing and infection","volume":"2","author":"Gavazzi","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.03.053_b0015","unstructured":"European Centre for Disease Prevention and Control. Mortality from influenza 2016 [Last accessed 7 December 2016]. Available from: http:\/\/www.ecdc.europa.eu\/en\/healthtopics\/H1N1\/basic_facts\/Pages\/mortality_from_influenza.aspx."},{"key":"10.1016\/j.vaccine.2018.03.053_b0020","unstructured":"European Respiratory Society. European Lung White Book. Chapter 18. Acute lower respiratory infections [Last accessed 7 December 2016]. Available from: http:\/\/www.erswhitebook.org\/chapters\/acute-lower-respiratory-infections\/."},{"key":"10.1016\/j.vaccine.2018.03.053_b0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2018.03.053_b0030","first-page":"461","article-title":"Vaccines against influenza WHO position paper \u2013 November 2012","volume":"87","author":"World Health Organisation","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2018.03.053_b0035","first-page":"1057","article-title":"Estimates of deaths associated with seasonal influenza \u2013 United States, 1976\u20132007","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2018.03.053_b0040","unstructured":"European Centre for Disease Prevention and Control. Revised estimates of deaths associated with seasonal influenza in the US 2010 [Last accessed 7 December 2016]. Available from: http:\/\/ecdc.europa.eu\/en\/activities\/sciadvice\/_layouts\/forms\/Review_DispForm.aspx?List=a3216f4c-f040-4f51-9f77-a96046dbfd72&ID=394."},{"key":"10.1016\/j.vaccine.2018.03.053_b0045","unstructured":"Sante Publique France (Public Health France). Surveillance de la grippe en France (Influenza surveillance in France) 2011 [Last accessed 7 December 2016]. Available from: http:\/\/www.invs.sante.fr\/Dossiers-thematiques\/Maladies-infectieuses\/Maladies-a-prevention-vaccinale\/Grippe\/Grippe-generalites\/Donnees-de-surveillance."},{"key":"10.1016\/j.vaccine.2018.03.053_b0050","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cger.2016.03.001","article-title":"Vaccinations for the older adult","volume":"32","author":"Gnanasekaran","year":"2016","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.vaccine.2018.03.053_b0055","unstructured":"European Centre for Disease Prevention and Control. Annual Epidemiological Report 2016 [Internet] Stockholm: ECDC; 2016 [Last accessed 7 December 2016]. Available from: http:\/\/ecdc.europa.eu\/en\/publications\/surveillance_reports\/annual_epidemiological_report\/Pages\/epi_index.aspx."},{"key":"10.1016\/j.vaccine.2018.03.053_b0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","article-title":"Clinical and economic burden of community-acquired pneumonia among adults in Europe","volume":"67","author":"Welte","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2018.03.053_b0065","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/irv.12398","article-title":"The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis","volume":"10","author":"Klein","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2018.03.053_b0070","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF03324909","article-title":"Herpes zoster and postherpetic neuralgia: a review of the effects of vaccination","volume":"21","author":"Johnson","year":"2009","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.vaccine.2018.03.053_b0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1090-3801(99)90015-0","article-title":"The lifetime occurrence of Herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population","volume":"3","author":"Bowsher","year":"1999","journal-title":"Eur J Pain"},{"key":"10.1016\/j.vaccine.2018.03.053_b0080","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2334-13-170","article-title":"Similar herpes zoster incidence across Europe: results from a systematic literature review","volume":"13","author":"Pinchinat","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.03.053_b0085","first-page":"571","article-title":"Postherpetic neuralgia","volume":"25","author":"Hope-Simpson","year":"1975","journal-title":"J R Coll Gen Pract."},{"key":"10.1016\/j.vaccine.2018.03.053_b0090","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1586\/14737175.7.11.1581","article-title":"Postherpetic neuralgia: epidemiology, pathophysiology and management","volume":"7","author":"Johnson","year":"2007","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.vaccine.2018.03.053_b0095","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1056\/NEJMct066061","article-title":"Varicella-zoster vaccine for the prevention of herpes zoster","volume":"356","author":"Kimberlin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.03.053_b0100","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.vaccine.2018.03.053_b0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2147\/TCRM.S47138","article-title":"Options for treating postherpetic neuralgia in the medically complicated patient","volume":"9","author":"Bruckenthal","year":"2013","journal-title":"Ther Clin Risk Manage"},{"key":"10.1016\/j.vaccine.2018.03.053_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002512-200724010-00001","article-title":"Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management","volume":"24","author":"Christo","year":"2007","journal-title":"Drugs Aging"},{"key":"10.1016\/j.vaccine.2018.03.053_b0115","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/j.jaad.2007.09.016","article-title":"Management of herpes zoster and postherpetic neuralgia","volume":"57","author":"Tyring","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.vaccine.2018.03.053_b0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11940-010-0098-1","article-title":"Herpes zoster ophthalmicus","volume":"13","author":"Sanjay","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.vaccine.2018.03.053_b0125","unstructured":"World Health Organisation. Diphtheria-tetanus-pertussis (DTP3) immunization coverage [Last accessed 7 December 2016]. Available from: http:\/\/www.who.int\/gho\/urban_health\/services\/dpt3_vaccination\/en\/."},{"key":"10.1016\/j.vaccine.2018.03.053_b0130","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3201\/eid2109.150023","article-title":"Tracking pertussis and evaluating control measures through enhanced pertussis surveillance, emerging infections program, United States","volume":"21","author":"Skoff","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.03.053_b0135","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1097\/INF.0000000000000795","article-title":"Pertussis across the globe: recent epidemiologic trends from 2000 to 2013","volume":"34","author":"Tan","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.03.053_b0140","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S0950268813000071","article-title":"Pertussis resurgence: waning immunity and pathogen adaptation \u2013 two sides of the same coin","volume":"142","author":"Mooi","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2018.03.053_b0145","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1542\/peds.2015-1120","article-title":"Sources of infant pertussis infection in the United States","volume":"136","author":"Skoff","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2018.03.053_b0150","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.vaccine.2012.11.052","article-title":"Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy","volume":"31","author":"Wiley","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.053_b0155","doi-asserted-by":"crossref","unstructured":"Htwe TH, Mushtaq A, Robinson SB, Rosher RB, Khardori N. Infection in the elderly. Infect Dis Clin North Am. 2007;21:711\u2013743, ix.","DOI":"10.1016\/j.idc.2007.07.006"},{"key":"10.1016\/j.vaccine.2018.03.053_b0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1586\/erv.10.26","article-title":"Vaccination and healthy aging","volume":"9","author":"Maggi","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.03.053_b0165","unstructured":"United Nations Department of Economic and Social Affairs (Population Division). Population ageing and the non-communicable diseases (2012\/1) 2012 [Last accessed 7 December 2016]. Available from: http:\/\/www.un.org\/en\/development\/desa\/population\/publications\/pdf\/popfacts\/popfacts_2012-1.1.pdf."},{"key":"10.1016\/j.vaccine.2018.03.053_b0170","doi-asserted-by":"crossref","first-page":"130389","DOI":"10.5888\/pcd11.130389","article-title":"Multiple chronic conditions among US adults: a 2012 update","volume":"11","author":"Ward","year":"2014","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.vaccine.2018.03.053_b0175","unstructured":"Centers for Disease Control and Prevention. Influenza. Chapter 12. In: Hamborsky J, Kroger A, Wolfe S, editors. Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington D.C.: Public Health Foundation; 2015."},{"key":"10.1016\/j.vaccine.2018.03.053_b0180","unstructured":"Centers for Disease Control and Prevention. Pneumococcal disease. Chapter 17. In: Hamborsky J, Kroger A, Wolfe S, editors. Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington D.C.: Public Health Foundation; 2015."},{"key":"10.1016\/j.vaccine.2018.03.053_b0185","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1161\/STROKEAHA.109.562017","article-title":"Increased risk of stroke after a herpes zoster attack: a population-based follow-up study","volume":"40","author":"Kang","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.vaccine.2018.03.053_b0190","first-page":"4","article-title":"Influenza and cardiovascular disease: is there a causal relationship?","volume":"31","author":"Madjid","year":"2004","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.vaccine.2018.03.053_b0195","doi-asserted-by":"crossref","first-page":"e69156","DOI":"10.1371\/journal.pone.0069156","article-title":"The short- and long-term risk of stroke after herpes zoster \u2013 a nationwide population-based cohort study","volume":"8","author":"Sreenivasan","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2018.03.053_b0200","first-page":"2724","article-title":"The link between seasonal influenza and NCDs: strategies for improving vaccination coverage","volume":"6","author":"Palache","year":"2014","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.vaccine.2018.03.053_b0205","first-page":"257","article-title":"Common infections in older adults","volume":"63","author":"Mouton","year":"2001","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.vaccine.2018.03.053_b0210","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/ageing\/afj048","article-title":"A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia","volume":"35","author":"van Seventer","year":"2006","journal-title":"Age Ageing"},{"key":"10.1016\/j.vaccine.2018.03.053_b0215","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1473-3099(08)70239-1","article-title":"Pneumococcal polysaccharide vaccine effectiveness: study quality must not be ignored","volume":"8","author":"Trotter","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.03.053_b0220","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1111\/j.1532-5415.2008.02023.x","article-title":"Recovery of activities of daily living in older adults after hospitalization for acute medical illness","volume":"56","author":"Boyd","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.vaccine.2018.03.053_b0225","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1532-5415.2003.51152.x","article-title":"Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age","volume":"51","author":"Covinsky","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.vaccine.2018.03.053_b0230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.eurger.2016.01.007","article-title":"The role of vaccination in successful independent ageing","volume":"7","author":"McElhaney","year":"2016","journal-title":"Eur Geriatr Med."},{"key":"10.1016\/j.vaccine.2018.03.053_b0235","first-page":"391","article-title":"Herpes zoster: the associated burden and its prevention","volume":"9","author":"Lang","year":"2011","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"},{"key":"10.1016\/j.vaccine.2018.03.053_b0240","first-page":"1044","article-title":"Impact of childhood immunization programs in 20th century France","volume":"60","author":"Gaillat","year":"2010","journal-title":"Rev Prat"},{"key":"10.1016\/j.vaccine.2018.03.053_b0245","unstructured":"Elsevier Health Sciences. Rapid references to influenza. Social and economic impact of influenza 2006 [Last accessed 7 December 2016]. Available from: http:\/\/www.rapidreferenceinfluenza.com\/chapter\/B978-0-7234-3433-7.50013-X\/aim\/social-impact."},{"key":"10.1016\/j.vaccine.2018.03.053_b0250","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1161\/01.CIR.102.25.3039","article-title":"Association of influenza vaccination and reduced risk of recurrent myocardial infarction","volume":"102","author":"Naghavi","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.vaccine.2018.03.053_b0255","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.vaccine.2014.01.029","article-title":"Influenza and pneumococcal vaccination and risk of stroke or transient ischaemic attack-matched case control study","volume":"32","author":"Siriwardena","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.053_b0260","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/MCP.0b013e3283218356","article-title":"Prophylactic vaccinations in chronic obstructive pulmonary disease: current status","volume":"15","author":"Varkey","year":"2009","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.vaccine.2018.03.053_b0265","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1016\/j.vaccine.2006.07.042","article-title":"Establishing the health and economic impact of influenza vaccination within the European Union 25 countries","volume":"24","author":"Ryan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.053_b0270","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/S0264-410X(02)00154-8","article-title":"Economic evaluation of strategies for the control and management of influenza in Europe","volume":"20","author":"Scuffham","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.053_b0275","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1108\/13663661111191257","article-title":"The socio-economic contribution of older people in the UK","volume":"15","author":"Cook","year":"2011","journal-title":"Working Older People"},{"key":"10.1016\/j.vaccine.2018.03.053_b0280","series-title":"Fiscal impact of adult vaccination in The Netherlands","first-page":"10","author":"Kotsopoulos","year":"2013"},{"key":"10.1016\/j.vaccine.2018.03.053_b0285","unstructured":"World Health Organisation. World report on ageing and health 2015 [Last accessed 7 December 2016]. Available from: http:\/\/www.who.int\/ageing\/publications\/world-report-2015\/en\/."},{"key":"10.1016\/j.vaccine.2018.03.053_b0290","unstructured":"Age UK. \u00a361 billion \u2013 the economic contribution of people aged 65 plus 2014 [Last accessed 7 December 2016]. Available from: http:\/\/www.ageuk.org.uk\/latest-press\/archive\/61-billion-the-economic-contribution-of-people-aged-65-plus\/."},{"key":"10.1016\/j.vaccine.2018.03.053_b0295","unstructured":"European Centre for Disease Prevention and Control. Vaccine scheduler 2016 [Last accessed 7 December 2016]. Available from: http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx."},{"key":"10.1016\/j.vaccine.2018.03.053_b0300","unstructured":"Swiss Federal Public Health Office. [Swiss vaccination plan for 2016] 2016 [Last accessed 7 December 2016]. Available from: http:\/\/www.infovac.ch\/fr\/?option=com_gd&view=listing&fid=941&task=ofile."},{"key":"10.1016\/j.vaccine.2018.03.053_b0305","unstructured":"World Health Organisation. WHO recommendations for routine immunization \u2013 summary tables 2016 [Last accessed 7 December 2016]. Available from: http:\/\/www.who.int\/immunization\/policy\/immunization_tables\/en\/."},{"key":"10.1016\/j.vaccine.2018.03.053_b0310","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1186\/1471-2458-14-813","article-title":"Annual public health and economic benefits of seasonal influenza vaccination: a European estimate","volume":"14","author":"Preaud","year":"2014","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.vaccine.2018.03.053_b0315","unstructured":"Control ECfDPa. Seasonal influenza vaccination in Europe \u2013 Vaccination recommendations and coverage rates, 2012\u201313 2015 [Last accessed 7 December 2016]. Available from: http:\/\/ecdc.europa.eu\/en\/publications\/_layouts\/forms\/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=1241."},{"key":"10.1016\/j.vaccine.2018.03.053_b0320","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4161\/hv.18629","article-title":"The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly","volume":"8","author":"Blank","year":"2012","journal-title":"Hum Vaccin Immunother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18304092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18304092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T06:35:22Z","timestamp":1589870122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18304092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":64,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0264410X18304092"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The public health value of vaccination for seniors in Europe","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}